A pooled safety and efficacy analysis examining the effect of performance status (PS) on outcomes in 9 first line treatment (rx) trials (cts) of 6,286 patients (pts) with metastatic colorectal cancer (MCRC).
- Citation:
- J Clin Oncol vol 25 (18s) abstr 4011
- Year:
- 2007
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Comprehensive
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Parents:
- None
- Children:
- 190
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- R. M. Goldberg C. H. Kohne M. T. Seymour A. De Gramont R. Porschen L. Saltz P. Rougier C. Tournigand A. Grothey D. J. Sargent
- Networks:
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- NCCTG-N0545, NCCTG-N9741
- Phases:
- 3, N/A
- Keywords: